Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 119,073 | 102,306 | 500 | 0 | 0 |
| Cost of Goods | 17,039 | 14,759 | N/A | N/A | N/A |
| Gross Profit | 102,034 | 87,547 | 500 | N/A | N/A |
| Operating Expenses | 60,770 | 56,483 | 35,795 | 18,680 | 19,280 |
| Operating Income | 41,303 | 31,823 | -35,295 | -18,680 | -19,280 |
| Other Income | 587 | 1,586 | 1,292 | 267 | 1,208 |
| Pre-tax Income | 41,890 | 33,409 | -34,004 | -18,412 | -18,073 |
| Income Tax | -33,093 | 1,534 | N/A | N/A | N/A |
| Net Income Continuous | 74,983 | 31,875 | -34,004 | -18,412 | -18,073 |
| Net Income | $74,983 | $31,875 | $-34,004 | $-18,412 | $-18,073 |
| EPS Basic Total Ops | 0.72 | 0.31 | -0.33 | -0.21 | -0.22 |
| EPS Basic Continuous Ops | 0.72 | 0.31 | -0.33 | -0.21 | -0.22 |
| EPS Diluted Total Ops | 0.71 | 0.30 | -0.33 | -0.21 | -0.22 |
| EPS Diluted Continuous Ops | 0.71 | 0.30 | -0.33 | -0.21 | -0.22 |
| EPS Diluted Before Non-Recurring Items | 0.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $41,395 | $32,122 | $-35,257 | $-18,634 | $-19,237 |